“I am very pleased to report that MATA has been awarded these monies for updating their advanced public transportation systems,” said Congressman Cohen. “I have made the improvement of our public transportation infrastructure in the 9th District a major priority during my tenure, and I applaud the DOT for awarding MATA the necessary funding to serve our community better.”
Last night, I was proud to vote for a major, comprehensive energy bill that will lower costs to consumers and American taxpayers, invest in renewable energy sources to create American jobs, expand domestic energy supply and create greater energy efficiency and conservation.
The Health Resources and Services Administration awarded a competing supplemental grant in the amount of $200,000 to the UT-HSC Boling Center for Developmental Disabilities for a training program and leadership education in neurodevelopmental disorders.
“Hispanic values – faith, family, love of country – are American values. The Hispanic dream – the hope of a better future – is the American Dream. During Hispanic Heritage Month, we honor the Hispanic community and pay tribute to the extraordinary contributions that Hispanics make to America all year long.
“I am very pleased to announce this huge contract for FedEx from USTRANSCOM,” said Congressman Cohen. “FedEx is second to none when it comes to providing global shipping, transport and logistics needs, so it is no surprise that the Department of Defense awarded them this contract. This contract will strengthen FedEx, and that is good for Memphis.”
“Isaac Hayes was a dear friend and supporter and I miss him profoundly” said Congressman Cohen. “He departed much too soon but left behind a remarkable musical legacy as well as host of friends and a loving family. Isaac’s artistic contributions, his encouragement of his fellow musicians and his support of young people will secure his place in history.”
Dr. Taylor’s research revolves around neurodegenerative disease, a condition in which cells of the brain and spinal cord are lost. He has stated, “The principal goal of our research is to reduce the morbidity and mortality associated with neurodegenerative disease.”